Stage 2 Stocks in Health Care
273 US stocks in Health Care are in Stage 2, the advancing phase of Weinstein's stage analysis. Listed below: those priced at $5 or more and trading at least $1 million a day on average, ranked by setup score and updated after every close (last close Oct 23, 2026).
| Stock | Close | 1D | Setup | Weeks in stage |
|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, Inc. | $10.20 | -6.08% | 9.4 | 14 |
| AMN AMN Healthcare Services Inc | $48.01 | +2.54% | 9.3 | 25 |
| PCRX Pacira BioSciences, Inc. | $36.42 | +0.22% | 9.2 | 2 |
| HSTM HealthStream, Inc. | $35.16 | +1.65% | 8.9 | 17 |
| MCK McKesson Corporation | $1,000.77 | -1.14% | 8.5 | 8 |
| MD Pediatrix Medical Group, Inc. | $29.29 | -0.88% | 8.4 | 26 |
| EXEL Exelixis, Inc. | $64.53 | -1.19% | 8.3 | 26 |
| FTRE Fortrea Holdings Inc. | $23.63 | -1.21% | 8.3 | 20 |
| CON Concentra Group Holdings Parent, Inc. | $39.25 | -1.80% | 8.3 | 22 |
| CDNA CareDx, Inc. | $69.21 | +0.07% | 8.2 | 24 |
| SLN Silence Therapeutics Plc | $19.67 | +0.05% | 8.2 | 1 |
| VEEV Veeva Systems Inc. Class A | $323.04 | +0.15% | 8.0 | 9 |
| KMTS Kestra Medical Technologies, Ltd. | $28.76 | +1.55% | 7.9 | 10 |
| MTD Mettler-Toledo International, Inc. | $1,670.29 | -0.85% | 7.9 | 9 |
| RCEL Avita Medical, Inc. | $15.51 | +0.58% | 7.9 | 13 |
| AMGN Amgen Inc. | $439.26 | -1.79% | 7.8 | 16 |
| RVTY Revvity, Inc. | $158.77 | +0.90% | 7.8 | 18 |
| CRL Charles River Laboratories International, Inc. | $345.37 | +1.68% | 7.8 | 16 |
| SIBN SI-BONE, Inc. | $21.48 | -0.37% | 7.8 | 13 |
| HALO Halozyme Therapeutics, Inc. | $125.63 | +0.88% | 7.8 | 16 |
| HNGE Hinge Health, Inc. Class A | $111.52 | +1.45% | 7.8 | 20 |
| HUM Humana Inc. | $422.07 | +0.26% | 7.8 | 2 |
| HAE Haemonetics Corporation | $118.51 | +2.02% | 7.8 | 18 |
| A Agilent Technologies, Inc. | $173.07 | -0.47% | 7.8 | 13 |
| CNC Centene Corporation | $70.17 | -1.50% | 7.8 | 1 |
| HTFL Heartflow, Inc. | $56.71 | +2.31% | 7.6 | 10 |
| NTRA Natera, Inc. | $403.95 | +0.64% | 7.6 | 20 |
| BIIB Biogen Inc. | $250.69 | -1.24% | 7.5 | 21 |
| PBYI Puma Biotechnology Inc | $11.02 | -2.13% | 7.5 | 69 |
| IOVA Iovance Biotherapeutics, Inc. | $14.09 | -0.35% | 7.5 | 19 |
| AVTR Avantor, Inc. | $17.29 | +0.82% | 7.4 | 12 |
| ILMN Illumina, Inc. | $269.42 | +0.01% | 7.4 | 24 |
| GMAB Genmab A/S | $43.79 | +9.47% | 7.4 | 9 |
| INFU InfuSystems Holdings, Inc. | $13.94 | -1.41% | 7.4 | 12 |
| CBLL CeriBell, Inc. | $27.13 | -0.99% | 7.4 | 11 |
| CAH Cardinal Health, Inc. | $249.57 | -2.37% | 7.4 | 1 |
| LLY Eli Lilly and Company | $1,273.46 | -2.54% | 7.3 | 1 |
| CI The Cigna Group | $306.95 | -2.83% | 7.3 | 1 |
| MASS 908 Devices Inc. | $11.49 | +1.23% | 7.2 | 24 |
| ARDT Ardent Health, Inc. | $12.27 | -0.73% | 7.2 | 12 |
| PCVX Vaxcyte, Inc. | $60.43 | -3.85% | 7.1 | 12 |
| MRNA Moderna, Inc. | $200.10 | -1.25% | 7.1 | 17 |
| BVS Bioventus Inc. Class A | $14.96 | -0.53% | 7.0 | 16 |
| VSTM Verastem, Inc. | $10.04 | -0.20% | 7.0 | 7 |
| ABBV AbbVie Inc. | $285.64 | +0.16% | 7.0 | 16 |
| QGEN Qiagen N.V. | $50.39 | +0.34% | 7.0 | 6 |
| LH Labcorp Holdings Inc. | $328.95 | -0.30% | 7.0 | 14 |
| COR Cencora, Inc. | $331.00 | -2.21% | 7.0 | 4 |
| WST West Pharmaceutical Services, Inc. | $392.15 | -0.48% | 7.0 | 24 |
| ARQT Arcutis Biotherapeutics, Inc. | $31.20 | -3.11% | 6.9 | 1 |
| GKOS Glaukos Corporation | $178.88 | +1.24% | 6.9 | 25 |
| CAI Caris Life Sciences, Inc. | $32.00 | +0.91% | 6.8 | 6 |
| DMAC DiaMedica Therapeutics Inc. | $8.72 | +1.04% | 6.8 | 2 |
| GRAL GRAIL, Inc. | $132.55 | +4.32% | 6.7 | 7 |
| CERT Certara, Inc. | $10.33 | +2.38% | 6.6 | 9 |
| MMSI Merit Medical Systems, Inc. | $93.30 | -0.68% | 6.6 | 10 |
| ELV Elevance Health, Inc. | $439.95 | -1.20% | 6.6 | 6 |
| OSCR Oscar Health, Inc. Class A | $30.99 | -6.99% | 6.6 | 22 |
| DNA Ginkgo Bioworks Holdings, Inc. Class A | $9.99 | +2.88% | 6.6 | 3 |
| BHC Bausch Health Companies Inc. | $6.44 | -0.77% | 6.6 | 6 |
Health Care: quick answers
Which stocks in Health Care are in an uptrend?
As of Oct 23, 2026, 273 US stocks in Health Care are in Stage 2, the uptrend phase. The largest by market value are Eli Lilly, AbbVie, Amgen, McKesson and Elevance Health.
How many stocks in Health Care are in Stage 2?
273 of the 1049 stocks we track in Health Care (26.0%) are in Stage 2. 80 are basing in Stage 1, 177 are topping in Stage 3 and 477 are in a Stage 4 downtrend. That share has fallen 6.2 points over the last 20 sessions.
Which stocks in Health Care entered Stage 2 recently?
11 stocks entered Stage 2 in the last four weeks: Silence Therapeutics (its first week), Centene (its first week), Cardinal Health (its first week), Eli Lilly (its first week), Cigna Group (its first week) and 6 more.
Daily screens
Every one recalculated after the close, with the exact criteria published on the page.
Stage 2 in other sectors & industries
US stocks in a confirmed uptrend (Stage 2, Weinstein’s advancing phase), grouped by sector and industry and ranked by setup score.